Stanford Medicine-led research finds Human brain is two separate organs
On Sept. 18, 2026, a study led by Stanford Medicine found the brain is two separate organs adjacent…
-
-
BioMarin to Acquire Alesta Therapeutics in Deal Valued at $490 Million to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia
On Aug. 18, 2026, BioMarin Pharmaceutical announced a definitive agreement to acquire Alesta Therapeutics to gain Alesta’s lead…
-
Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC
On Jul. 29, 2026, Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and…
-
FDA Approves Tylenol Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
-
FDA Approves Johnson & Johnson Market Authorization for OTTAVA™ Robotic Surgical System in the U.S.
On Jul. 22, 2026, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted…
-
Lilly to acquire AtaiBeckley for $3.8 billion advancing therapies for treatment-resistant depression
On Jul. 16, 2026, Eli Lilly and AtaiBeckley, a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health…
-
Merck’s LIPFENDRA® (enlicitide) Approved by the FDA to Reduce Cholesterol
On Jul. 16, 2026, Merck announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA® (enlicitide) tablets…
-
Johnson & Johnson Invests more than $1 Billion to Strengthen Contact Lens Manufacturing in Jacksonville, Florida
On Jun. 15, 2026, Johnson & Johnson announced an investment of more than $1 billion in Jacksonville, Florida…
-
Sun Pharma, India’s Largest drug Firm to Buy U.S., to Acquire Organon for $11.75 Billion
On Apr. 27, 2026, Sun Pharmaceutical Industries and Organon announced they have entered into an agreement under which…
-
Princeton scientists make 3D bio-electronic hybrid system using brain cells
On Apr. 24, 2026, researchers at Princeton University announce they have developed a 3-dimensional device that merges living…
-
Biotechnology | Disease | Neurology | Oncology | Pharmaceutical | Quantum
Merck to Acquire Terns Pharmaceuticals for $5.7 Billion, Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
-
An analysis of 2.2 million people reveals shared and substance-specific genetic pathways for addiction risk
On Mar. 20, 2026, researchers of a Rutgers Health–led study led by Holly Poore, a faculty instructor of psychiatry…
-
U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for Treatment of Adults with Psoriatic Arthritis
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
-
Biotechnology | Disease | FDA
FDA approves Novo Nordisk’s Sogroya® as first and only once-weekly, long-acting growth hormone for three additional pediatric indications
On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…
-
Merck and Mayo Clinic Announce R&D Collaboration Supporting AI-Enabled Drug Discovery and Precision Medicine
On Feb. 18, 2026, Merck, known as MSD outside of the U.S. and Canada, and Mayo Clinic, the…
-
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
On Feb. 18, 2026, Johnson & Johnson announced announced a more than $1 billion investment in a next…
-
US measles outbreak tops 2,000 known infections
On Dec. 29, 2025, measles cases nationwide have reached 2,012, the Centers for Disease Control and Prevention (CDC)…
-
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
-
Novartis and U.S. government reach agreement on lowering drug prices
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
On Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
-
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
-
FDA | Medicine | Therapeutics
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…
-
FDA Withdraws Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
On Nov. 28, 2025, The Food and Drug Administration (FDA) announced the withdrawal of the proposed rule entitled…
-
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
-
Merck to Acquire Cidara Therapeutics for $9.2 Billion, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
-
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
On Nov. 13, 2025, Legend Biotech announced the official opening and ribbon cutting of its new, state-of-the-art research…
-
New Jersey man’s death first one to be tied to tick-related meat allergy
On Nov. 13, 2025, a previously healthy New Jersey man has been identified by an allergist at the…
-
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
-
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
-
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
